TRIB logo

Trinity Biotech (TRIB) Company Overview

Profile

Full Name:

Trinity Biotech plc

Sector:

Healthcare

Country:

Ireland

IPO:

October 21, 1992

Indexes:

Not included

Description:

Trinity Biotech (TRIB) is a biotechnology company that develops and manufactures diagnostic products. They focus on tests for infectious diseases, diabetes, and other medical conditions. Their products help healthcare professionals diagnose and monitor patients, improving health outcomes worldwide.

Key Details

Price

$0.66

Annual Revenue

$56.83 M(-9.10% YoY)

Annual EPS

-$3.20(+46.67% YoY)

Annual ROE

100.29%

Beta

0.24

Events Calendar

Earnings

Next earnings date:

Apr 4, 2025

Recent quarterly earnings:

Nov 15, 2024

Recent annual earnings:

Apr 4, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Jun 5, 2015
Splits

Next split:

N/A

Recent split:

Feb 23, 2024

Analyst ratings

Recent major analysts updates

Oct 5, 16 Stephens & Co.
Equal-weight
May 29, 15 Stephens & Co.
Overweight
Apr 30, 14 Roth Capital
Buy
Mar 5, 13 Craig-Hallum
Buy
Jan 22, 13 Roth Capital
Neutral
Dec 11, 12 CJS Securities
Market Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Trinity Biotech?
  • Does Trinity Biotech pay dividends?
  • What sector is Trinity Biotech in?
  • What industry is Trinity Biotech in?
  • What country is Trinity Biotech based in?
  • When did Trinity Biotech go public?
  • Is Trinity Biotech in the S&P 500?
  • Is Trinity Biotech in the NASDAQ 100?
  • Is Trinity Biotech in the Dow Jones?
  • When was Trinity Biotech's last earnings report?
  • When does Trinity Biotech report earnings?
  • Should I buy Trinity Biotech stock now?

What is the ticker symbol for Trinity Biotech?

The ticker symbol for Trinity Biotech is NASDAQ:TRIB

Does Trinity Biotech pay dividends?

No, Trinity Biotech does not pay dividends

What sector is Trinity Biotech in?

Trinity Biotech is in the Healthcare sector

What industry is Trinity Biotech in?

Trinity Biotech is in the Medical Devices industry

What country is Trinity Biotech based in?

Trinity Biotech is headquartered in Ireland

When did Trinity Biotech go public?

Trinity Biotech's initial public offering (IPO) was on October 21, 1992

Is Trinity Biotech in the S&P 500?

No, Trinity Biotech is not included in the S&P 500 index

Is Trinity Biotech in the NASDAQ 100?

No, Trinity Biotech is not included in the NASDAQ 100 index

Is Trinity Biotech in the Dow Jones?

No, Trinity Biotech is not included in the Dow Jones index

When was Trinity Biotech's last earnings report?

Trinity Biotech's most recent earnings report was on Nov 15, 2024

When does Trinity Biotech report earnings?

The next expected earnings date for Trinity Biotech is Apr 4, 2025

Should I buy Trinity Biotech stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions